| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 3 | |
| #2 | Australia | 2 | |
| #3 | Canada | 2 | |
| #4 | China | 1 | |
| #5 | EPO (European Patent Office) | 1 | |
| #6 | Israel | 1 | |
| #7 | Republic of Korea | 1 | |
| #8 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Croci Alberto Murat | 11 |
| #2 | Karlin Michael Joseph | 11 |
| #3 | Lai Norman Zhennan | 11 |
| #4 | Tan Yuebin | 8 |
| #5 | De La Cruz Jr Vidal Felix | 7 |
| #6 | Feinson Roy | 3 |
| #7 | De La Cruz Vidal Felix | 3 |
| #8 | De La Cruz Jr | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021026488A2 | Use of pcbp1 to generate induced pluripotent stem cells while inhibiting oncogenesis | |
| AU2019358060A1 | Antibodies directed to filamin-A and therapeutic uses thereof | |
| US2021113714A1 | Use of pcbp1 to treat hyperproliferative disease |